GSK News, GSK Quote, GSK Quote

GSK (NY:GSK) Delayed: 50.67 --0 (-0%)

Prev. Close

$50.67

Today 6M 1Y 5Y

Open

$50.67

52 Wk High

$45.58

52 Wk Low

$37.82

Day High

$50.67

Day Low

$50.67

P/E

N/A

EPS

$0.00

Volume

1,568

Friends, Peers and Foes (?): GSK:LN, PFE, AZN, NVS, MRK (more...)

ALERTS | RSS

Jun 17, 2026 04:21 PM FDA approves GSK and Spero's oral carbapenem antibiotic Utebzi
Jun 17, 2026 04:21 PM Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
Jun 17, 2026 12:36 PM Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs)
Jun 17, 2026 12:21 PM Form 11-K GSK plc For: Dec 31
Jun 17, 2026 12:05 PM Form 11-K GSK plc For: Dec 31
Jun 17, 2026 12:02 PM Form 6-K GSK plc For: Jun 17
Jun 17, 2026 11:09 AM GSK receives FDA approval for oral antibiotic to treat UTIs
Jun 15, 2026 10:02 AM Form 6-K GSK plc For: Jun 15
Jun 15, 2026 06:08 AM German government to drop variable drug discounting plans - Reuters
Jun 12, 2026 06:33 AM Form 6-K GSK plc For: Jun 12

Entities mentioned with GSK

View All Entities